Complex effects of Ras proto-oncogenes in tumorigenesis

Roberto Diaz, Lluis Lopez-Barcons, Daniel Ahn, Antonio Garcia-Espana, Andrew Yoon, Jeremy Matthews, Ramon Mangues, Roman Perez-Soler, Angel Pellicer

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Ras proteins have been found mutated in about one-third of human tumors. In vitro, Ras has been shown to regulate distinct and contradictory effects, such as cellular proliferation and apoptosis. Nonetheless, the effects that the wild-type protein elicits in tumorigenesis are poorly understood. Depending on the type of tissue, Ras proto-oncogenes appear to either promote or inhibit the tumor phenotype. In this report, we treated wild-type and N-ras knockout mice with 3-methylcholanthrene (MCA) to induce fibrosarcomas and found that MCA is more carcinogenic in wild-type mice than in knockout mice. After injecting different doses of a tumorigenic cell line, the wild-type mice exhibited a shorter latency of tumor development than the knockouts, indicating that there are N-ras-dependent differences in the stromal cells. Likewise, we have analyzed B-cell lymphomas induced by either N-methylnitrosourea or by the N-ras oncogene in mice that over-express the N-ras proto-oncogene and found that the over-expression of wild-type N-ras is able to increase the incidence of these lymphomas. Considered together, our results indicate that Ras proto-oncogenes can enhance or inhibit the malignant phenotype in vivo in different systems.

Original languageEnglish (US)
Pages (from-to)535-539
Number of pages5
Issue number4
StatePublished - Apr 2004

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Complex effects of Ras proto-oncogenes in tumorigenesis'. Together they form a unique fingerprint.

Cite this